| Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ... Blood advances 3 (12), 1826-1836, 2019 | 106 | 2019 |
| Health literacy of adults presenting to an urban ED T Olives, R Patel, S Patel, J Hottinger, JR Miner The American journal of emergency medicine 29 (8), 875-882, 2011 | 72 | 2011 |
| Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia MJ Wieduwilt, L Metheny III, MJ Zhang, HL Wang, N Estrada-Merly, ... Blood advances 6 (1), 339-357, 2022 | 47 | 2022 |
| Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide A Im, A Rashidi, T Wang, M Hemmer, ML MacMillan, J Pidala, M Jagasia, ... Biology of blood and marrow transplantation 26 (8), 1459-1468, 2020 | 41 | 2020 |
| Relapse and disease-free survival in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation using older matched sibling donors vs … GSG Murthy, S Kim, ZH Hu, N Estrada-Merly, MB Abid, M Aljurf, U Bacher, ... JAMA oncology 8 (3), 404-411, 2022 | 40 | 2022 |
| Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy SR Solomon, A St Martin, NN Shah, G Fatobene, MM Al Malki, KK Ballen, ... Blood advances 3 (19), 2836-2844, 2019 | 40 | 2019 |
| Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era B Dhakal, S Patel, S Girnius, L Bachegowda, R Fraser, O Davila, ... Leukemia 34 (12), 3338-3347, 2020 | 32 | 2020 |
| Kidney Transplant Patients' Perceptions, Beliefs, and Barriers Related to Regular Nephrology Outpatient Visits K Goldade, S Sidhwani, S Patel, L Brendt, J Vigliaturo, B Kasiske, ... American Journal of Kidney Diseases 57 (1), 11-20, 2011 | 29 | 2011 |
| Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myeloma DJ Fall, H Stessman, SS Patel, Z Sachs, BG Van Ness, LB Baughn, ... Journal of Cancer 5 (9), 720, 2014 | 25 | 2014 |
| Randomized Clinical Trial of the Effect of Supplemental Opioids in Procedural Sedation with Propofol on Serum Catecholamines JR Miner, JC Moore, D Plummer, RO Gray, S Patel, JD Ho Academic Emergency Medicine 20 (4), 330-337, 2013 | 25 | 2013 |
| 558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT … S Pal, B Tran, J Haanen, M Hurwitz, A Sacher, N Agarwal, N Tannir, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 24 | 2022 |
| Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome A Singh, CE Dandoy, M Chen, S Kim, CM Mulroney, MA Kharfan-Dabaja, ... Transplantation and cellular therapy 28 (1), 48. e1-48. e10, 2022 | 24 | 2022 |
| Alfentanil for Procedural Sedation in the Emergency Department JR Miner, R Gray, P Delavari, S Patel, R Patel, D Plummer Annals of Emergency Medicine 57 (2), 117-121, 2011 | 23 | 2011 |
| Prognostic Factors for Mortality among Day+ 100 Survivors after Allogeneic Hematopoietic Cell Transplantation SS Patel, LA Rybicki, D Corrigan, B Bolwell, R Dean, H Liu, AT Gerds, ... Biology of Blood and Marrow Transplantation 24 (5), 1029-1034, 2018 | 21 | 2018 |
| Reduced intensity conditioning for acute myeloid leukemia using melphalan-vs busulfan-based regimens: a CIBMTR report Z Zhou, R Nath, J Cerny, HL Wang, MJ Zhang, H Abdel-Azim, V Agrawal, ... Blood advances 4 (13), 3180-3190, 2020 | 18 | 2020 |
| Impact of Second Primary Malignancy Post-Autologous Transplantation on Outcomes of Multiple Myeloma: A CIBMTR Analysis BK Ragon, MV Shah, A D'Souza, N Estrada-Merly, L Gowda, G George, ... Blood advances, bloodadvances. 2022009138, 2023 | 17 | 2023 |
| Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis RM Saliba, AM Alousi, J Pidala, M Arora, SR Spellman, MT Hemmer, ... Transplantation and cellular therapy 28 (10), 681-693, 2022 | 16 | 2022 |
| Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and … CM Mulroney, MB Abid, A Bashey, RF Chemaly, SO Ciurea, M Chen, ... British journal of haematology 194 (1), 145-157, 2021 | 16 | 2021 |
| Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis GSG Murthy, S Kim, N Estrada-Merly, MB Abid, M Aljurf, A Assal, T Badar, ... Haematologica, 2023 | 15 | 2023 |
| Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of … RF Cornell, R Fraser, L Costa, S Goodman, N Estrada-Merly, C Lee, ... Transplantation and Cellular Therapy 27 (3), 264. e1-264. e7, 2021 | 15 | 2021 |
James MinerUniversity of MinnesotaVerified email at umn.edu
